The CD34+CD38− AML cells seem to include leukemic stem cells, and the CD34+CD38− AML cell burden may therefore also reflect the AML stem cell burden; this may be the reason for the prognostic impact of the CD34+CD38− AML cell level. This evidence concerns the gene CD34 and acute myeloid leukemia.